Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Systematic budget analysis reveals errors and inefficiencies. This primer shows how to review income, expenses, and allocations effectively.
17,750 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
In the first half of 2026, Upstart stock fell about 19%, shaking confidence in a fintech darling. This article breaks...
A regulatory hint sent Moderna stock just popped, but the journey from acceptance to approval matters. This guide bre...
Investors keep asking: is plug power stock: dead, or does the hydrogen quest still offer a path to strong gains? This...
As March opens, SoFi Technologies jumps after an active insider purchase by CEO Anthony Noto. This deep dive breaks d...
Polestar stock plunged 29% in a single week. There was no obvious single news trigger, but a mix of market forces and...
A discreet fund quietly builds a Mattel stake, signaling conviction or a calculated thesis. This article breaks down ...
As AI brings new pricing for memory, Micron stands at the crossroads of momentum and valuation. This guide breaks dow...
A sudden explosion at Valero’s Port Arthur refinery prompted a temporary shutdown, sending ripples through energy mar...
Apyx Medical (APYX) 2026 is shaping up as a pivotal year for investors. This guide breaks down how to read the Q1 tra...
Nexxn (NEXN) 2026 earnings signal how the company is navigating growth, profitability, and capital allocation. This g...